£120.00

This is the most expensive it has ever been. Walk away.

£120 today · previous high £120 · all-time low £115

CRC Press Patient-Reported Outcomes Biostatistics Book

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days · 90 data points

Historical
Generating forecast…
£120.00 £114.55 £115.74 £116.93 £118.12 £119.31 £120.50 23 July 2026 14 August 2026 05 September 2026 27 September 2026 20 October 2026
View at Amazon ↗

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
9 days 81 days · current 0 20 41 61 81 £115 £120 Days at Price

Price Analysis

Most common price: £120 (81 days, 90.0%)

Price range: £115 - £120

Price levels: 2 different prices over 90 days

Description
Patient-Reported Outcomes: Measurement, Implementation and Interpretation is a specialized volume within the Chapman and Hall/CRC Biostatistics Series. This book assists biopharmaceutical researchers and health science professionals in understanding the quantitative aspects of PRO methodology. It provides an up-to-date look at the conceptual and analytical issues involved in developing and validating patient-reported outcome measures. By covering key concepts related to the measurement, implementation, and interpretation of these tools, the text helps readers enrich their technical knowledge and practical application of PRO measures in research settings.

Key Features

This book is part of the Chapman and Hall/CRC Biostatistics Series, specifically Volume 64.

The text focuses on the development, validation, and use of patient-reported outcome (PRO) measures.

It provides a quantitative perspective on PRO methodology for health sciences professionals.

The content covers essential conceptual and analytical issues regarding PRO measures.

Designed specifically for biopharmaceutical researchers and the health sciences community.

Product Specifications
Brand
CRC Press
Format
hardcover
ASIN
1439873674
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners
Domain
Amazon UK
Release Date
20 December 2013
Listed Since
14 February 2011

Barcode

No barcode data available

Similar Products You Might Like

Patient-Reported Outcomes: Measurement, Implementation and Interpretation (Chapman & Hall/CRC Biostatistics Series)
99% match

Patient-Reported Outcomes: Measurement, Implementation and Interpretation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£54.49 19 Oct 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
96% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£119.36 24 Sep 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
96% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£49.07 18 Sep 2026
Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)
96% match

Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)

Springer

£108.01 02 Oct 2026
Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)
96% match

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£77.05 01 Oct 2026
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
95% match

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£75.00 17 Sep 2026
Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
95% match

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Springer

£45.86 10 Sep 2026
Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
95% match

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Springer

£65.60 08 Sep 2026
Clinical Trial Data Analysis Using R and SAS (Chapman & Hall/CRC Biostatistics Series)
95% match

Clinical Trial Data Analysis Using R and SAS (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£108.90 22 Sep 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
95% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£64.03 22 Sep 2026
Patient-Reported Outcomes and Experience: Measuring What We Want From PROMs and PREMs
95% match

Patient-Reported Outcomes and Experience: Measuring What We Want From PROMs and PREMs

Springer

£47.33 15 Oct 2026
Clinical Trial Data Analysis Using R and SAS (Chapman & Hall/CRC Biostatistics Series)
95% match

Clinical Trial Data Analysis Using R and SAS (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£51.99 26 Aug 2026
Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)
95% match

Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£65.84 19 Sep 2026
Clinical Trial Biostatistics and Biopharmaceutical Applications
95% match

Clinical Trial Biostatistics and Biopharmaceutical Applications

CRC Press

£100.00 12 Sep 2026
Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
95% match

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£120.00 24 Sep 2026
Success Probability Estimation with Applications to Clinical Trials
95% match

Success Probability Estimation with Applications to Clinical Trials

Wiley

£84.95 12 Sep 2026
Quality of Life: The Assessment, Analysis and Reporting of Patient-reported Outcomes
95% match

Quality of Life: The Assessment, Analysis and Reporting of Patient-reported Outcomes

Wiley

£75.29 12 Aug 2026
Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
95% match

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£48.44 23 Sep 2026
Statistical Methods in Biomarker and Early Clinical Development
95% match

Statistical Methods in Biomarker and Early Clinical Development

Springer

£100.11 19 Aug 2026
Principles and Practice of Clinical Research
95% match

Principles and Practice of Clinical Research

Elsevier

£87.38 15 Aug 2026
Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)
95% match

Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£103.19 24 Aug 2026
Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)
95% match

Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)

SAS Institute

£70.10 02 Oct 2026
Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)
95% match

Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£125.00 17 Sep 2026
Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)
95% match

Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£47.99 08 Sep 2026